145
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Association of Nuclear Factor Erythroid-2-Related Actor 2 Gene Polymorphisms with Diabetic Nephropathy in Chinese Patients

, , , , &
Pages 1231-1237 | Published online: 07 Apr 2021

References

  • Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380(9854):1662–1673. doi:10.1016/S0140-6736(12)61350-6
  • Adler A, Casula A, Steenkamp R, et al. Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.K. Diabetes Care. 2014;37(5):1304–1311. doi:10.2337/dc13-0553
  • Zheng S, Powell DW, Zheng F, et al. Diabetic nephropathy: proteinuria, inflammation, and fibrosis. J Diabetes Res. 2016;2016:5241549.
  • Xu X, Sun J, Chang X, et al. Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China. J Cell Mol Med. 2016;20(11):2078–2088. doi:10.1111/jcmm.12900
  • Moi P, Chan K, Asunis I, et al. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA. 1994;91(21):9926–9930. doi:10.1073/pnas.91.21.9926
  • Cho HY. Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2. Oxid Med Cell Longev. 2013;2013:286524. doi:10.1155/2013/286524
  • Canning P, Sorrell FJ, Bullock AN. Structural basis of Keap1 interactions with Nrf2. Free Radic Biol Med. 2015;88(Pt B):101–107. doi:10.1016/j.freeradbiomed.2015.05.034
  • Zenkov NK, Menshchikova EB, Tkachev VO. Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target. Biochemistry (Mosc). 2013;78(1):19–36. doi:10.1134/S0006297913010033
  • Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med. 2004;36(10):1199–1207. doi:10.1016/j.freeradbiomed.2004.02.074
  • Itoh K, Tong KI, Yamamoto M. Molecular mechanism activating nrf2–keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med. 2004;36(10):1208–1213. doi:10.1016/j.freeradbiomed.2004.02.075
  • Ruiz S, Pergola PE, Zager RA, et al. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013;83(6):1029–1041. doi:10.1038/ki.2012.439
  • Korytina GF, Akhmadishina LZ, Aznabaeva YG, et al. Associations of the NRF2/KEAP1 pathway and antioxidant defense gene polymorphisms with chronic obstructive pulmonary disease. Gene. 2019;692:102–112. doi:10.1016/j.gene.2018.12.061
  • Chen S, Pan H, Chen Y, et al. Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study. Sci Rep. 2019;9(1):14311. doi:10.1038/s41598-019-50706-y
  • Yamaguchi Y, Kamai T, Higashi S, et al. Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer. BMC Cancer. 2019;19(1):1137. doi:10.1186/s12885-019-6347-0
  • Jiménez-Osorio AS, González-Reyes S, García-Niño WR, et al. Association of nuclear factor-erythroid 2-related factor 2, thioredoxin interacting protein, and heme oxygenase-1 gene polymorphisms with diabetes and obesity in mexican patients. Oxid Med Cell Longev. 2016;2016:7367641. doi:10.1155/2016/7367641
  • Wang X, Chen H, Liu J, et al. Association between the NF-E2 related factor 2 gene polymorphism and oxidative stress, anti-oxidative status, and newly-diagnosed type 2 diabetes mellitus in a chinese population. Int J Mol Sci. 2015;16(7):16483–16496. doi:10.3390/ijms160716483
  • Shimoyama Y, Mitsuda Y, Tsuruta Y, et al. Polymorphism of Nrf2, an antioxidative gene, is associated with blood pressure and cardiovascular mortality in hemodialysis patients. Int J Med Sci. 2014;11(7):726–731. doi:10.7150/ijms.8590
  • Reszka E, Jablonowski Z, Wieczorek E, et al. Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients. J Cancer Res Clin Oncol. 2014;140(10):1723–1731. doi:10.1007/s00432-014-1733-0
  • Marzec JM, Christie JD, Reddy SP, et al. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J. 2007;21(9):2237–2246. doi:10.1096/fj.06-7759com
  • Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/S0140-6736(12)60033-6
  • Priestley JR, Kautenburg KE, Casati MC, et al. The NRF2 knockout rat: a new animal model to study endothelial dysfunction, oxidant stress, and microvascular rarefaction. Am J Physiol Heart Circ Physiol. 2016;310(4):H478–87. doi:10.1152/ajpheart.00586.2015
  • Marczak ED, Marzec J, Zeldin DC, et al. Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans. Pharmacogenet Genomics. 2012;22(8):620–628. doi:10.1097/FPC.0b013e32835516e5
  • Jha JC, Banal C, Chow BS, et al. Diabetes and kidney disease: role of oxidative stress. Antioxid Redox Signal. 2016;25(12):657–684. doi:10.1089/ars.2016.6664
  • Cheng AS, Cheng YH, Lee CY, et al. Resveratrol protects against methylglyoxal-induced hyperglycemia and pancreatic damage in vivo. Nutrients. 2015;7(4):2850–2865. doi:10.3390/nu7042850
  • Jung KA, Choi BH, Nam CW, et al. Identification of aldo-keto reductases as NRF2-target marker genes in human cells. Toxicol Lett. 2013;218(1):39–49. doi:10.1016/j.toxlet.2012.12.026
  • Cho HY, Gladwell W, Yamamoto M, et al. Exacerbated airway toxicity of environmental oxidant ozone in mice deficient in Nrf2. Oxid Med Cell Longev. 2013;2013:254069. doi:10.1155/2013/254069
  • Aoki Y, Sato H, Nishimura N, et al. Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl Pharmacol. 2001;173(3):154–160. doi:10.1006/taap.2001.9176